Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 680

1.

Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.

Urabe M, Ushiku T, Shinozaki-Ushiku A, Iwasaki A, Yamazawa S, Yamashita H, Seto Y, Fukayama M.

Cancer Med. 2018 Sep 21. doi: 10.1002/cam4.1763. [Epub ahead of print]

2.

High CCR4 expression in the tumor microenvironment is a poor prognostic indicator in lung adenocarcinoma.

Karasaki T, Qiang G, Anraku M, Sun Y, Shinozaki-Ushiku A, Sato E, Kashiwabara K, Nagayama K, Nitadori JI, Sato M, Murakawa T, Kakimi K, Fukayama M, Nakajima J.

J Thorac Dis. 2018 Aug;10(8):4741-4750. doi: 10.21037/jtd.2018.07.45.

3.

Correlations between the Recurrence Patterns and Sizes of Lateral Pelvic Lymph Nodes before and after Chemoradiotherapy in Patients with Lower Rectal Cancer.

Shiratori H, Kawai K, Hata K, Tanaka T, Nishikawa T, Sasaki K, Kaneko M, Murono K, Emoto S, Morikawa T, Fukayama M, Nozawa H.

Oncology. 2018 Sep 13:1-11. doi: 10.1159/000492493. [Epub ahead of print]

PMID:
30212816
4.

Identification of Liver Fibrosis Using the Hepatic Vein Waveform in Patients with Fontan Circulation.

Nakatsuka T, Soroida Y, Nakagawa H, Shindo T, Sato M, Soma K, Nakagomi R, Kobayashi T, Endo M, Hikita H, Sato M, Gotoh H, Iwai T, Yasui M, Shinozaki-Ushiku A, Shiraga K, Asakai H, Hirata Y, Fukayama M, Ikeda H, Yatomi Y, Tateishi R, Inuzuka R, Koike K.

Hepatol Res. 2018 Sep 4. doi: 10.1111/hepr.13248. [Epub ahead of print]

PMID:
30182424
5.

Three types of metaplasia models through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.

Kinoshita H, Hayakawa Y, Konishi M, Hata M, Tsuboi M, Hayata Y, Hikiba Y, Ihara S, Nakagawa H, Ikenoue T, Ushiku T, Fukayama M, Hirata Y, Koike K.

J Pathol. 2018 Aug 31. doi: 10.1002/path.5163. [Epub ahead of print]

PMID:
30168144
6.

Development and internal validation of a risk scoring system for gastrointestinal events requiring surgery in gastrointestinal lymphoma patients.

Aoki T, Yamada A, Takahashi M, Niikura R, Toyama K, Ushiku T, Kurokawa M, Momose T, Fukayama M, Koike K.

J Gastroenterol Hepatol. 2018 Aug 27. doi: 10.1111/jgh.14452. [Epub ahead of print]

PMID:
30151937
7.

Chemical Landscape for Tissue Clearing Based on Hydrophilic Reagents.

Tainaka K, Murakami TC, Susaki EA, Shimizu C, Saito R, Takahashi K, Hayashi-Takagi A, Sekiya H, Arima Y, Nojima S, Ikemura M, Ushiku T, Shimizu Y, Murakami M, Tanaka KF, Iino M, Kasai H, Sasaoka T, Kobayashi K, Miyazono K, Morii E, Isa T, Fukayama M, Kakita A, Ueda HR.

Cell Rep. 2018 Aug 21;24(8):2196-2210.e9. doi: 10.1016/j.celrep.2018.07.056.

8.

The prognostic value of PD-L1 expression in upper tract urothelial carcinoma varies according to platelet count.

Miyama Y, Morikawa T, Miyakawa J, Koyama Y, Kawai T, Kume H, Fukayama M.

Cancer Med. 2018 Sep;7(9):4330-4338. doi: 10.1002/cam4.1686. Epub 2018 Jul 31.

9.

Frequent CLDN18-ARHGAP fusion in highly metastatic diffuse-type gastric cancer with relatively early onset.

Tanaka A, Ishikawa S, Ushiku T, Yamazawa S, Katoh H, Hayashi A, Kunita A, Fukayama M.

Oncotarget. 2018 Jun 29;9(50):29336-29350. doi: 10.18632/oncotarget.25464. eCollection 2018 Jun 29.

10.

Prognostic factors of Erdheim-Chester Disease: A nationwide survey in Japan.

Toya T, Ogura M, Toyama K, Yoshimi A, Shinozaki-Ushiku A, Honda A, Honda K, Hosoya N, Murakami Y, Kawashima H, Nannya Y, Arai S, Nakamura F, Shinoda Y, Nangaku M, Miyagawa K, Fukayama M, Moriya-Saito A, Katayama I, Ogura T, Kurokawa M.

Haematologica. 2018 Jul 5. pii: haematol.2018.190728. doi: 10.3324/haematol.2018.190728. [Epub ahead of print]

11.

Host MICA Polymorphism as a Potential Predictive Marker in Response to Chemotherapy for Colorectal Liver Metastases.

Nishioka Y, Shindoh J, Inagaki Y, Gonoi W, Mitsui J, Abe H, Yoshioka R, Yoshida S, Fukayama M, Tsuji S, Hashimoto M, Hasegawa K, Kokudo N.

Dig Dis. 2018 Jul 3:1-9. doi: 10.1159/000490411. [Epub ahead of print]

PMID:
29969766
12.

MED12 is frequently mutated in ovarian and other adnexal Leiomyomas.

Li Z, Maeda D, Kudo-Asabe Y, Tamura D, Nanjo H, Hayashi A, Ikemura M, Fukayama M, Goto A.

Hum Pathol. 2018 Jun 23. pii: S0046-8177(18)30224-7. doi: 10.1016/j.humpath.2018.06.013. [Epub ahead of print]

PMID:
29944972
13.

Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.

Fukayama M, Kunita A, Kaneda A.

Adv Exp Med Biol. 2018;1045:437-457. doi: 10.1007/978-981-10-7230-7_20.

PMID:
29896679
14.

MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression.

Kunita A, Morita S, Irisa TU, Goto A, Niki T, Takai D, Nakajima J, Fukayama M.

Sci Rep. 2018 Jun 11;8(1):8838. doi: 10.1038/s41598-018-27128-3.

15.

A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer.

Saito K, Isayama H, Sakamoto Y, Nakai Y, Ishigaki K, Tanaka M, Watadani T, Arita J, Takahara N, Mizuno S, Kogure H, Ijichi H, Tateishi K, Tada M, Hasegawa K, Fukayama M, Kokudo N, Koike K.

Med Oncol. 2018 May 30;35(7):100. doi: 10.1007/s12032-018-1158-8.

PMID:
29846849
16.

Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.

Furuya G, Abe H, Shinozaki-Ushiku A, Yamashita A, Ihara S, Hirata Y, Chiba A, Fujioka Y, Kurokawa M, Koike K, Fukayama M.

Pathol Res Pract. 2018 Jul;214(7):1051-1055. doi: 10.1016/j.prp.2018.05.022. Epub 2018 May 22.

PMID:
29843925
17.

Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.

Enooku K, Kondo M, Fujiwara N, Sasako T, Shibahara J, Kado A, Okushin K, Fujinaga H, Tsutsumi T, Nakagomi R, Minami T, Sato M, Nakagawa H, Kondo Y, Asaoka Y, Tateishi R, Ueki K, Ikeda H, Yoshida H, Moriya K, Yotsuyanagi H, Kadowaki T, Fukayama M, Koike K.

J Gastroenterol. 2018 May 10. doi: 10.1007/s00535-018-1472-0. [Epub ahead of print]

PMID:
29749571
18.

Pancreatic Lipomatous Hamartoma: A Hitherto Unrecognized Variant.

Tanaka M, Ushiku T, Ikemura M, Takazawa Y, Igari T, Shimizu M, Yamaguchi H, Fukushima N, Sakuma K, Arita J, Sakamoto Y, Hasegawa K, Watadani T, Nakai Y, Koike K, Fukayama M.

Am J Surg Pathol. 2018 Jul;42(7):891-897. doi: 10.1097/PAS.0000000000001075.

PMID:
29738363
19.

Glomeruloid hemangioma associated with TAFRO syndrome.

Shinozaki-Ushiku A, Higashihara T, Ikemura M, Sato J, Nangaku M, Ushiku T, Fukayama M.

Hum Pathol. 2018 Apr 24. pii: S0046-8177(18)30140-0. doi: 10.1016/j.humpath.2018.04.011. [Epub ahead of print]

PMID:
29702119
20.

Blood Vessel Invasion Is a Strong Predictor of Postoperative Recurrence in Endometrial Cancer.

Sato M, Taguchi A, Fukui Y, Kawata A, Taguchi S, Kashiyama T, Eguchi S, Inoue T, Tomio K, Tanikawa M, Sone K, Mori M, Nagasaka K, Adachi K, Ikemura M, Domoto Y, Arimoto T, Oda K, Fukayama M, Osuga Y, Fujii T.

Int J Gynecol Cancer. 2018 Jun;28(5):875-881. doi: 10.1097/IGC.0000000000001262.

PMID:
29664845
21.

Histological transformation of MALT lymphoma to plasma cell leukemia after rituximab-containing therapy.

Suzuki Y, Honda A, Nakazaki K, Mizuno H, Ikemura M, Shinozaki-Ushiku A, Nakamura F, Fukayama M, Kurokawa M.

Ann Hematol. 2018 Jul;97(7):1297-1298. doi: 10.1007/s00277-018-3300-2. Epub 2018 Mar 26. No abstract available.

PMID:
29582109
22.

Sessile serrated adenoma detection rate is correlated with adenoma detection rate.

Ohki D, Tsuji Y, Shinozaki T, Sakaguchi Y, Minatsuki C, Kinoshita H, Niimi K, Ono S, Hayakawa Y, Yoshida S, Yamada A, Kodashima S, Yamamichi N, Hirata Y, Ushiku T, Fujishiro M, Fukayama M, Koike K.

World J Gastrointest Oncol. 2018 Mar 15;10(3):82-90. doi: 10.4251/wjgo.v10.i3.82.

23.

CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells.

Abe H, Saito R, Ichimura T, Iwasaki A, Yamazawa S, Shinozaki-Ushiku A, Morikawa T, Ushiku T, Yamashita H, Seto Y, Fukayama M.

Virchows Arch. 2018 Apr;472(4):643-651. doi: 10.1007/s00428-018-2332-2. Epub 2018 Mar 13.

PMID:
29536167
24.

Eculizumab treatment for ischemic enteritis accompanied with paroxysmal nocturnal hemoglobinuria: a case report and literature review.

Yasunaga M, Taoka K, Nakagawa H, Yamada A, Abe H, Jona M, Nishikawa M, Nakazaki K, Yatomi Y, Fukayama M, Koike K, Kurokawa M.

Ann Hematol. 2018 Aug;97(8):1513-1515. doi: 10.1007/s00277-018-3286-9. Epub 2018 Mar 13. No abstract available.

PMID:
29532162
25.

Extraskeletal osteosarcoma: MDM2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity.

Makise N, Sekimizu M, Kubo T, Wakai S, Watanabe SI, Kato T, Kinoshita T, Hiraoka N, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Histopathology. 2018 Jul;73(1):147-156. doi: 10.1111/his.13506. Epub 2018 Apr 19.

PMID:
29489027
26.

Synergistic Cytotoxic Effect on Gastric Cancer Cells of an Immunotoxin Cocktail in Which Antibodies Recognize Different Epitopes on CDH17.

Kusano-Arai O, Iwanari H, Kudo S, Kikuchi C, Yui A, Akiba H, Matsusaka K, Kaneda A, Fukayama M, Tsumoto K, Hamakubo T.

Monoclon Antib Immunodiagn Immunother. 2018 Feb;37(1):1-11. doi: 10.1089/mab.2017.0043.

PMID:
29474162
27.

A 19-Gauge Histology Needle Versus a 19-Gauge Standard Needle in Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Solid Lesions: A Multicenter Randomized Comparison Study (GREATER Study).

Iwashita T, Nakai Y, Mukai T, Togawa O, Matsubara S, Hatano Y, Hara A, Tanaka M, Shibahara J, Fukayama M, Isayama H, Yasuda I.

Dig Dis Sci. 2018 Apr;63(4):1043-1051. doi: 10.1007/s10620-018-4913-y. Epub 2018 Feb 21.

PMID:
29464585
28.

Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front.

Kunita A, Baeriswyl V, Meda C, Cabuy E, Takeshita K, Giraudo E, Wicki A, Fukayama M, Christofori G.

Am J Pathol. 2018 May;188(5):1276-1288. doi: 10.1016/j.ajpath.2018.01.016. Epub 2018 Feb 17.

PMID:
29458011
29.

Distinct Chemopreventive Effects of Aspirin in Diffuse and Intestinal-Type Gastric Cancer.

Niikura R, Hayakawa Y, Hirata Y, Konishi M, Suzuki N, Ihara S, Yamada A, Ushiku T, Fujishiro M, Fukayama M, Koike K.

Cancer Prev Res (Phila). 2018 May;11(5):279-286. doi: 10.1158/1940-6207.CAPR-17-0276. Epub 2018 Feb 16.

PMID:
29453233
30.

CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.

Fujiwara N, Nakagawa H, Enooku K, Kudo Y, Hayata Y, Nakatsuka T, Tanaka Y, Tateishi R, Hikiba Y, Misumi K, Tanaka M, Hayashi A, Shibahara J, Fukayama M, Arita J, Hasegawa K, Hirschfield H, Hoshida Y, Hirata Y, Otsuka M, Tateishi K, Koike K.

Gut. 2018 Aug;67(8):1493-1504. doi: 10.1136/gutjnl-2017-315193. Epub 2018 Feb 6.

PMID:
29437870
31.

The Japanese Society of Pathology Guidelines on the handling of pathological tissue samples for genomic research: Standard operating procedures based on empirical analyses.

Kanai Y, Nishihara H, Miyagi Y, Tsuruyama T, Taguchi K, Katoh H, Takeuchi T, Gotoh M, Kuramoto J, Arai E, Ojima H, Shibuya A, Yoshida T, Akahane T, Kasajima R, Morita KI, Inazawa J, Sasaki T, Fukayama M, Oda Y.

Pathol Int. 2018 Feb;68(2):63-90. doi: 10.1111/pin.12631.

PMID:
29431262
32.

Protrusion on the Depressed Surface of Non-polypoid T1 Colorectal Cancer Is Associated with Venous Invasion.

Shinagawa T, Hata K, Morikawa T, Takiyama H, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Nozawa H, Ishihara S, Nakamura H, Fukayama M, Watanabe T.

Anticancer Res. 2018 Feb;38(2):993-1002.

PMID:
29374732
33.

Value of FDG-PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer.

Okuno T, Kawai K, Koyama K, Takahashi M, Ishihara S, Momose T, Morikawa T, Fukayama M, Watanabe T.

Dis Colon Rectum. 2018 Mar;61(3):320-327. doi: 10.1097/DCR.0000000000000959.

PMID:
29360680
34.

Transparency-enhancing technology allows three-dimensional assessment of gastrointestinal mucosa: A porcine model.

Mizutani H, Ono S, Ushiku T, Kudo Y, Ikemura M, Kageyama N, Yamamichi N, Fujishiro M, Someya T, Fukayama M, Koike K, Onodera H.

Pathol Int. 2018 Feb;68(2):102-108. doi: 10.1111/pin.12627. Epub 2018 Jan 17.

PMID:
29341375
35.

Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.

Makise N, Sekimizu M, Kubo T, Wakai S, Hiraoka N, Komiyama M, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Am J Surg Pathol. 2018 May;42(5):656-664. doi: 10.1097/PAS.0000000000001014.

PMID:
29309298
36.

Nine primary malignant neoplasms-involving the esophagus, stomach, colon, rectum, prostate, and external ear canal-without microsatellite instability: a case report.

Arakawa K, Hata K, Yamamoto Y, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Nozawa H, Yoshida M, Fukuhara H, Fujishiro M, Morikawa T, Yamasoba T, Koike K, Fukayama M, Watanabe T.

BMC Cancer. 2018 Jan 4;18(1):24. doi: 10.1186/s12885-017-3973-2.

37.

Gastric pyloric gland adenoma: a multicentre clinicopathological study of 67 cases.

Choi WT, Brown I, Ushiku T, Yozu M, Setia N, Srivastava A, Johncilla M, Pai RK, Gill RM, Fukayama M, Misdraji J, Lauwers GY.

Histopathology. 2018 May;72(6):1007-1014. doi: 10.1111/his.13460. Epub 2018 Mar 5.

PMID:
29278427
38.

EVI1 modulates oncogenic role of GPC1 in pancreatic carcinogenesis.

Tanaka M, Ishikawa S, Ushiku T, Morikawa T, Isagawa T, Yamagishi M, Yamamoto H, Katoh H, Takeshita K, Arita J, Sakamoto Y, Hasegawa K, Kokudo N, Fukayama M.

Oncotarget. 2017 Sep 1;8(59):99552-99566. doi: 10.18632/oncotarget.20601. eCollection 2017 Nov 21.

39.

Clinical features and outcomes of secondary intraocular lymphoma.

Karakawa A, Taoka K, Kaburaki T, Tanaka R, Shinozaki-Ushiku A, Hayashi H, Miyagi-Maeshima A, Nishimura Y, Uekusa T, Kojima Y, Fukayama M, Kurokawa M, Aihara M.

Br J Haematol. 2017 Nov 16. doi: 10.1111/bjh.15005. [Epub ahead of print] No abstract available.

PMID:
29143310
40.

Lipocalin-type prostaglandin D synthase-derived PGD2 attenuates malignant properties of tumor endothelial cells.

Omori K, Morikawa T, Kunita A, Nakamura T, Aritake K, Urade Y, Fukayama M, Murata T.

J Pathol. 2018 Jan;244(1):84-96. doi: 10.1002/path.4993. Epub 2017 Nov 10.

PMID:
29124765
41.

Digital quantitative analysis of mast cell infiltration in interstitial cystitis.

Akiyama Y, Maeda D, Morikawa T, Niimi A, Nomiya A, Yamada Y, Igawa Y, Goto A, Fukayama M, Homma Y.

Neurourol Urodyn. 2018 Feb;37(2):650-657. doi: 10.1002/nau.23365. Epub 2017 Oct 24.

PMID:
29065222
42.

Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome.

Tsukui D, Kanda H, Shinozaki-Ushiku A, Tateishi S, Takeshima Y, Nagafuchi Y, Sasaki O, Iwasaki Y, Harada H, Shibuya M, Sumitomo S, Shoda H, Kubo K, Fujio K, Nakamura F, Kurokawa M, Fukayama M, Yamamoto K.

Mod Rheumatol. 2018 Jul;28(4):621-625. doi: 10.1080/14397595.2017.1387223. Epub 2017 Oct 23.

PMID:
29057700
43.

Loss of Stromal Antigen 2 (STAG2) Expression in Upper Urinary Tract Carcinoma: Differential Prognostic Effect According to the Ki-67 Proliferating Index.

Miyakawa J, Morikawa T, Miyama Y, Nakagawa T, Kawai T, Homma Y, Fukayama M.

Ann Surg Oncol. 2017 Dec;24(13):4059-4066. doi: 10.1245/s10434-017-6097-7. Epub 2017 Oct 2.

PMID:
28967037
44.

Histone modification alteration coordinated with acquisition of promoter DNA methylation during Epstein-Barr virus infection.

Funata S, Matsusaka K, Yamanaka R, Yamamoto S, Okabe A, Fukuyo M, Aburatani H, Fukayama M, Kaneda A.

Oncotarget. 2017 Jul 21;8(33):55265-55279. doi: 10.18632/oncotarget.19423. eCollection 2017 Aug 15.

45.

Giant gastrointestinal stromal tumor of the vermiform appendix: A case report.

Kaneko M, Kawai K, Murono K, Nishikawa T, Sasaki K, Otani K, Yasuda K, Tanaka T, Kiyomatsu T, Hata K, Nozawa H, Ishihara S, Hayashi A, Shinozaki-Ushiku A, Fukayama M, Watanabe T.

Mol Clin Oncol. 2017 Sep;7(3):399-403. doi: 10.3892/mco.2017.1334. Epub 2017 Jul 19.

46.

Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets.

Mine S, Hishima T, Suganuma A, Fukumoto H, Sato Y, Kataoka M, Sekizuka T, Kuroda M, Suzuki T, Hasegawa H, Fukayama M, Katano H.

Sci Rep. 2017 Aug 31;7(1):10188. doi: 10.1038/s41598-017-10684-5.

47.

A case of delayed exacerbation of interstitial lung disease after discontinuation of temsirolimus.

Matsuki R, Okuda K, Mitani A, Yamauchi Y, Tanaka G, Kume H, Homma Y, Hinata M, Hayashi A, Shibahara J, Fukayama M, Nagase T.

Respir Med Case Rep. 2017 Aug 11;22:158-163. doi: 10.1016/j.rmcr.2017.08.008. eCollection 2017.

48.

Results of a 36-year surveillance program for ulcerative colitis-associated neoplasia in the Japanese population.

Kishikawa J, Hata K, Kazama S, Anzai H, Shinagawa T, Murono K, Kaneko M, Sasaki K, Yasuda K, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Nozawa H, Ishihara S, Morikawa T, Fukayama M, Watanabe T.

Dig Endosc. 2018 Mar;30(2):236-244. doi: 10.1111/den.12955. Epub 2017 Nov 2.

PMID:
28836702
49.

Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus.

Okabe A, Funata S, Matsusaka K, Namba H, Fukuyo M, Rahmutulla B, Oshima M, Iwama A, Fukayama M, Kaneda A.

Sci Rep. 2017 Aug 11;7(1):7924. doi: 10.1038/s41598-017-08370-7.

50.

Detection of residual metastatic tumor in the brain following Gamma Knife radiosurgery using a single or a series of magnetic resonance imaging scans: An autopsy study.

Sakuramachi M, Igaki H, Ikemura M, Yamashita H, Okuma K, Sekiya N, Hayakawa Y, Sakumi A, Takahashi W, Hasegawa H, Fukayama M, Nakagawa K.

Oncol Lett. 2017 Aug;14(2):2033-2040. doi: 10.3892/ol.2017.6359. Epub 2017 Jun 9.

Supplemental Content

Loading ...
Support Center